Reply

Affiliations

Comment

Ivana Carey et al. Hepatology. 2021 Feb.

. 2021 Feb;73(2):870-871.

doi: 10.1002/hep.31468.

No abstract available

Comment on

Pregenomic HBV RNA and Hepatitis B Core-Related Antigen Predict Outcomes in Hepatitis B e Antigen-Negative Chronic Hepatitis B Patients Suppressed on Nucleos(T)ide Analogue Therapy.
Carey I, Gersch J, Wang B, Moigboi C, Kuhns M, Cloherty G, Dusheiko G, Agarwal K. Carey I, et al. Hepatology. 2020 Jul;72(1):42-57. doi: 10.1002/hep.31026. Hepatology. 2020. PMID: 31701544
Letter to the Editor: Use of Pregenomic Hepatitis B Virus RNA and Hepatitis B Core-Related Antigen to Predict Cure of Hepatitis B Virus Infection.
Chan HL. Chan HL. Hepatology. 2021 Feb;73(2):870. doi: 10.1002/hep.31469. Epub 2021 Jan 21. Hepatology. 2021. PMID: 32687649 No abstract available.

1. Carey I, Gersch J, Wang B, Moigboi C, Kuhns M, Cloherty G, et al. Pre‐genomic HBV RNA and HBcrAg predict outcomes in HBeAg negative CHB patients suppressed on nucleos(t)ide analogue therapy. Hepatology 2020;72:42‐57.
1. Hadziyannis JS, Sevastianos V, Rapti I, Vassilopoulos HE. Sustained responses and loss of HBsAg in HBeAg‐negative patients with CHB who stop long‐term treatment with adefovir. Gastroenterology 2012;143:629‐636.
1. Butler EK, Gersch J, McNamara A, Luk KC, Holzmayer V, de Medina M, et al. HBV serum DNA and RNA levels in nucleos(t)ide analog‐treated or untreated patients during chronic and acute infection. Hepatology 2018;68:2106‐2117.